Protective effect of chaperones on polyglutamine diseases
被引:30
作者:
Kobayashi, Y
论文数: 0引用数: 0
h-index: 0
机构:
Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, JapanNagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan
Kobayashi, Y
[1
]
Sobue, G
论文数: 0引用数: 0
h-index: 0
机构:
Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, JapanNagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan
Sobue, G
[1
]
机构:
[1] Nagoya Univ, Grad Sch Med, Dept Neurol, Showa Ku, Nagoya, Aichi 4668550, Japan
Polyglutamine diseases are inherited neurodegenerative diseases caused by the expansion of polyglutamine tract in the disease causing gene products. Studies of polyglutamine disease patients and transgenic mice have revealed that nuclear inclusions formed by the disease protein are a common pathological feature of these diseases. The finding that nuclear inclusions are ubiquitinated raises the possibility that alterations in the major intracellular system for degrading proteins, the ubiquitin-proteasome pathway, may be involved in the pathogenesis of polyglutamine diseases. Perturbations in proteasome function are associated with altered expression levels of stress-response or heat shock proteins. Heat shock proteins function as molecular chaperones, which recognize and renaturate misfolded protein (aggregate). In this article, we review the role of chaperones in the development of polyglutamine diseases. Overexpression of chaperones reduces aggregate formation and suppresses apoptosis in several polyglutamine disease models including spinal and bulbar muscular atrophy. These facts indicate that chaperones; may be one of the key factors in the development of polyglutamine disease, and suggest that increasing expression level or enhancing the function of chaperones will provide an avenue for the treatment of polyglutamine disease. (C) 2001 Elsevier Science Inc.